652 related articles for article (PubMed ID: 27261915)
21. Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).
Palma DA; Nguyen TK; Kwan K; Gaede S; Landis M; Malthaner R; Fortin D; Louie AV; Frechette E; Rodrigues GB; Yaremko B; Yu E; Dar AR; Lee TY; Gratton A; Warner A; Ward A; Inculet R
Radiat Oncol; 2017 Jan; 12(1):30. PubMed ID: 28129789
[TBL] [Abstract][Full Text] [Related]
22. Nonsurgical Therapy for Early-Stage Lung Cancer.
Daly ME; Beagen P; Madani MH
Hematol Oncol Clin North Am; 2023 Jun; 37(3):499-512. PubMed ID: 37024386
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of hepatic oligometastases with stereotactic ablative radiotherapy and radiofrequency ablation in an anaplastic lymphoma kinase fusion-positive lung cancer patient.
Weber B; Liu M; Sobkin P; Morris SW; Hout D; van der Westhuizen N; Tonseth RP; Saltman DL
J Med Radiat Sci; 2016 Mar; 63(1):67-70. PubMed ID: 27087977
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.
Shinde A; Li R; Kim J; Salgia R; Hurria A; Amini A
Semin Oncol; 2018 Aug; 45(4):210-219. PubMed ID: 30286944
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage Lung Cancer - A Done Deal?
Gulstene S; Ruwanpura T; Palma D; Joseph N
Clin Oncol (R Coll Radiol); 2022 Nov; 34(11):733-740. PubMed ID: 36050221
[TBL] [Abstract][Full Text] [Related]
26. Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial.
Louie AV; van Werkhoven E; Chen H; Smit EF; Paul MA; Widder J; Groen HJ; van den Borne BE; De Jaeger K; Slotman BJ; Senan S
Radiother Oncol; 2015 Oct; 117(1):44-8. PubMed ID: 26492839
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options.
Boujelbene N; Elloumi F; Kamel ME; Abeidi H; Matzinger O; Mirimanoff RO; Khanfir K
Swiss Med Wkly; 2013; 143():w13780. PubMed ID: 23740331
[TBL] [Abstract][Full Text] [Related]
28. Treatment of medically inoperable non-small-cell lung cancer with stereotactic body radiation therapy versus image-guided tumor ablation: can interventional radiology compete?
Dupuy DE
J Vasc Interv Radiol; 2013 Aug; 24(8):1139-45. PubMed ID: 23796858
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.
Nanda RH; Liu Y; Gillespie TW; Mikell JL; Ramalingam SS; Fernandez FG; Curran WJ; Lipscomb J; Higgins KA
Cancer; 2015 Dec; 121(23):4222-30. PubMed ID: 26348268
[TBL] [Abstract][Full Text] [Related]
30. The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer.
Guerrero E; Ahmed M
Lung Cancer; 2016 Feb; 92():22-8. PubMed ID: 26775592
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic ablative radiotherapy for medically inoperable early stage lung cancer: early outcomes.
Chan OS; Yeung RM; Hung AW; Lee MC; Chang AT; Chan CC; Lee AW
Hong Kong Med J; 2012 Oct; 18(5):412-8. PubMed ID: 23018069
[TBL] [Abstract][Full Text] [Related]
33. [Stereotactic radiotherapy is established treatment in localized non-small cell lung cancer].
Sailas L; Virsunen H
Duodecim; 2016; 132(6):571-5. PubMed ID: 27132296
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer.
Palma D; Senan S
Curr Opin Oncol; 2011 Mar; 23(2):133-9. PubMed ID: 21107257
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
Aridgides P; Bogart J
Thorac Surg Clin; 2016 Aug; 26(3):261-9. PubMed ID: 27427521
[TBL] [Abstract][Full Text] [Related]
36. Local Ablative Therapies in Oligometastatic NSCLC: New Data and New Directions.
Lang P; Gomez DR; Palma DA
Semin Respir Crit Care Med; 2020 Jun; 41(3):369-376. PubMed ID: 32450591
[TBL] [Abstract][Full Text] [Related]
37. [Stereotactic body radiation radiotherapy for oligometastatic non-small cell lung cancer (NSCLC): A case report].
Leduc C; Antoni D; Quoix É; Noël G
Cancer Radiother; 2015 May; 19(3):192-7. PubMed ID: 25841992
[TBL] [Abstract][Full Text] [Related]
38. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.
Nguyen NP; Garland L; Welsh J; Hamilton R; Cohen D; Vinh-Hung V
Cancer Treat Rev; 2008 Dec; 34(8):719-27. PubMed ID: 18657910
[TBL] [Abstract][Full Text] [Related]
39. [Extracranial stereotactic radiotherapy for early-stage non-small cell lung cancer and oligometastases].
Riesterer O
Praxis (Bern 1994); 2013 Oct; 102(21):1309-16. PubMed ID: 24129299
[TBL] [Abstract][Full Text] [Related]
40. Alternatives to surgery for early stage non-small cell lung cancer-ready for prime time?
Das M; Abdelmaksoud MH; Loo BW; Kothary N
Curr Treat Options Oncol; 2010 Jun; 11(1-2):24-35. PubMed ID: 20577833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
